Study types
- article 1
Condition tags
- endometriosis 1
Frequent coauthors
- Chaojie Chen 1
- Qiong Wang 1
- Ren-ai Xu 1
- Shunbin Luo 1
article
2021
Elagolix, as a competitive gonadotropin-releasing hormone (GnRH) receptor antagonist, has been recently approved by the US FDA for the management of moderate to severe pain due to endometriosis in women. In this study, we developed and veri…